000 01075 a2200337 4500
005 20250512090756.0
264 0 _c19720516
008 197205s 0 0 jpn d
022 _a0022-1961
040 _aNLM
_beng
_cNLM
100 1 _aOka, S
245 0 0 _a[Chemotherapy].
_h[electronic resource]
260 _bNaika. Internal medicine
_c1972
300 _a78-82 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aAsparaginase
_xpharmacology
650 0 4 _aBleomycin
_xpharmacology
650 0 4 _aCephalosporins
_xpharmacology
650 0 4 _aCytarabine
_xpharmacology
650 0 4 _aDaunorubicin
_xpharmacology
650 0 4 _aDrug Therapy
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
650 0 4 _aHumans
650 0 4 _aKanamycin
_xpharmacology
650 0 4 _aPenicillins
_xpharmacology
650 0 4 _aRifampin
_xpharmacology
650 0 4 _aVincristine
_xpharmacology
700 1 _aOizumi, K
773 0 _tNaika. Internal medicine
_gvol. 29
_gno. 1
_gp. 78-82
999 _c4116579
_d4116579